Latest News

Horizon Therapeutics plc Announces Changes in Research and Development Organization

DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced changes to its research and development organization structure. Effective immediately, Elizabeth H.Z. Thompson, Ph.D., group vice president, clinical development and external search; Srini Ramanathan, Ph.D., group vice president, development sciences and San Francisco site head and Melanie Gloria, senior vice president, R&D operations, will report to Timothy Walbert, chairman, president and chief executive offi

Source link

Related posts

Global Stethoscope Market to 2026 – Industry Analysis, Trends, Market Size, and Forecasts –


Medical News Today: Study suggests avocados suppress hunger, but can we trust the research?


Luke Perry Dies of "Massive Stroke"


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy